160 related articles for article (PubMed ID: 31129110)
1. A Retrospective Study of Comorbidities and Complications in Elderly Acute Myeloid Leukemia Patients in the United States.
Dhopeshwarkar N; Iqbal S; Wang X; Salas M
Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):e436-e456. PubMed ID: 31129110
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and outcomes of elderly patients with acute myeloid leukemia who receive no treatment in the Surveillance, Epidemiology and End Results-Medicare database.
Dharmani C; Wang E; Tu N; Salas M; Kamel YM
Future Oncol; 2023 Jan; 19(2):159-171. PubMed ID: 36912693
[TBL] [Abstract][Full Text] [Related]
3. Elderly patients with acute myeloid leukemia who only receive supportive care in the Surveillance, Epidemiology and End Results-Medicare database: demographics, treatment patterns and outcomes.
Dharmani C; Wang E; Tu N; Fofah O; Cueto J; Salas M; Kamel YM
Future Oncol; 2023 Aug; 19(24):1677-1693. PubMed ID: 37345543
[TBL] [Abstract][Full Text] [Related]
4. Mortality and Vascular Events Among Elderly Patients With Chronic Myeloid Leukemia: A Retrospective Analysis of Linked SEER-Medicare Data.
Lang K; McGarry LJ; Huang H; Dorer D; Kaufman E; Knopf K
Clin Lymphoma Myeloma Leuk; 2016 May; 16(5):275-285.e1. PubMed ID: 27013180
[TBL] [Abstract][Full Text] [Related]
5. Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs.
Meyers J; Yu Y; Kaye JA; Davis KL
Appl Health Econ Health Policy; 2013 Jun; 11(3):275-86. PubMed ID: 23677706
[TBL] [Abstract][Full Text] [Related]
6. Comorbidity, age, and mortality among adults treated intensively for acute myeloid leukemia (AML).
Tawfik B; Pardee TS; Isom S; Sliesoraitis S; Winter A; Lawrence J; Powell BL; Klepin HD
J Geriatr Oncol; 2016 Jan; 7(1):24-31. PubMed ID: 26527394
[TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
[TBL] [Abstract][Full Text] [Related]
8. Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States.
Medeiros BC; Satram-Hoang S; Hurst D; Hoang KQ; Momin F; Reyes C
Ann Hematol; 2015 Jul; 94(7):1127-38. PubMed ID: 25791241
[TBL] [Abstract][Full Text] [Related]
9. Excess mortality, length of stay, and costs associated with serious fungal infections among elderly cancer patients: findings from linked SEER-Medicare data.
Menzin J; Lang KM; Friedman M; Dixon D; Marton JP; Wilson J
Value Health; 2005; 8(2):140-8. PubMed ID: 15804322
[TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukemia and myelodysplastic syndrome after adjuvant chemotherapy: A population-based study among older breast cancer patients.
Rosenstock AS; Niu J; Giordano SH; Zhao H; Wolff AC; Chavez-MacGregor M
Cancer; 2018 Mar; 124(5):899-906. PubMed ID: 29236294
[TBL] [Abstract][Full Text] [Related]
11. Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era.
Morton LM; Dores GM; Schonfeld SJ; Linet MS; Sigel BS; Lam CJK; Tucker MA; Curtis RE
JAMA Oncol; 2019 Mar; 5(3):318-325. PubMed ID: 30570657
[TBL] [Abstract][Full Text] [Related]
12. Statewide geographic variation in outcomes for adults with acute myeloid leukemia in North Carolina.
Freeman AT; Meyer AM; Smitherman AB; Zhou L; Basch EM; Shea TC; Wood WA
Cancer; 2016 Oct; 122(19):3041-50. PubMed ID: 27351768
[TBL] [Abstract][Full Text] [Related]
13. The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma - a Swedish population-based study.
Mohammadi M; Cao Y; Glimelius I; Bottai M; Eloranta S; Smedby KE
BMC Cancer; 2015 Nov; 15():850. PubMed ID: 26537111
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors of childhood and adolescent acute myeloid leukemia (AML) survival: evidence from four decades of US population data.
Hossain MJ; Xie L; Caywood EH
Cancer Epidemiol; 2015 Oct; 39(5):720-6. PubMed ID: 26159683
[TBL] [Abstract][Full Text] [Related]
15. Sex disparity in childhood and young adult acute myeloid leukemia (AML) survival: Evidence from US population data.
Hossain MJ; Xie L
Cancer Epidemiol; 2015 Dec; 39(6):892-900. PubMed ID: 26520618
[TBL] [Abstract][Full Text] [Related]
16. Temporal patterns and predictors of receiving no active treatment among older patients with acute myeloid leukemia in the United States: A population-level analysis.
Zeidan AM; Podoltsev NA; Wang X; Bewersdorf JP; Shallis RM; Huntington SF; Gore SD; Davidoff AJ; Ma X; Wang R
Cancer; 2019 Dec; 125(23):4241-4251. PubMed ID: 31483484
[TBL] [Abstract][Full Text] [Related]
17. Burden of comorbidities is higher among elderly survivors of oropharyngeal cancer compared with controls.
Bigelow EO; Blackford AL; Eytan DF; Eisele DW; Fakhry C
Cancer; 2020 Apr; 126(8):1793-1803. PubMed ID: 31943172
[TBL] [Abstract][Full Text] [Related]
18. Improved survival among older acute myeloid leukemia patients - a population-based study.
Shah BK; Ghimire KB
Acta Oncol; 2014 Jul; 53(7):935-8. PubMed ID: 24913154
[TBL] [Abstract][Full Text] [Related]
19. Survival differences in childhood and young adult acute myeloid leukemia: A cross-national study using US and England data.
Xie S; Hossain MJ
Cancer Epidemiol; 2018 Jun; 54():19-24. PubMed ID: 29554538
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Follow-Up and Impact of Comorbidity before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia-Lessons Learned from the Prospective BRIDGE Trial.
Middeke JM; Herbst R; Parmentier S; Bug G; Hänel M; Stuhler G; Schäfer-Eckart K; Rösler W; Klein S; Bethge W; Bitz U; Büttner B; Knoth H; Alakel N; Schaich M; Morgner A; Kramer M; Sockel K; von Bonin M; Stölzel F; Platzbecker U; Röllig C; Thiede C; Ehninger G; Bornhäuser M; Schetelig J
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1491-1497. PubMed ID: 28527985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
